Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.

Couroux P, Patel D, Armstrong K, Larché M, Hafner RP.

Clin Exp Allergy. 2015 May;45(5):974-81. doi: 10.1111/cea.12488.

PMID:
25600085
2.

A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy.

Schwartz S, Etropolski MS, Shapiro DY, Rauschkolb C, Vinik AI, Lange B, Cooper K, Van Hove I, Haeussler J.

Clin Drug Investig. 2015 Feb;35(2):95-108. doi: 10.1007/s40261-014-0249-3.

3.

Helicase-primase inhibitor pritelivir for HSV-2 infection.

Wald A, Corey L, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Kriesel J, Fife K, Galitz L, Stoelben S, Huang ML, Selke S, Stobernack HP, Ruebsamen-Schaeff H, Birkmann A.

N Engl J Med. 2014 Jan 16;370(3):201-10. doi: 10.1056/NEJMoa1301150.

4.
5.

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

Patel D, Couroux P, Hickey P, Salapatek AM, Laidler P, Larché M, Hafner RP.

J Allergy Clin Immunol. 2013 Jan;131(1):103-9.e1-7. doi: 10.1016/j.jaci.2012.07.028. Epub 2012 Sep 13.

6.

Safety, pharmacokinetic, and pharmacodynamic profiles of ipragliflozin (ASP1941), a novel and selective inhibitor of sodium-dependent glucose co-transporter 2, in patients with type 2 diabetes mellitus.

Schwartz SL, Akinlade B, Klasen S, Kowalski D, Zhang W, Wilpshaar W.

Diabetes Technol Ther. 2011 Dec;13(12):1219-27. doi: 10.1089/dia.2011.0012. Epub 2011 Aug 19.

PMID:
21854192
8.

Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study.

Berg JK, Shenouda SK, Heilmann CR, Gray AL, Holcombe JH.

Diabetes Obes Metab. 2011 Nov;13(11):982-9. doi: 10.1111/j.1463-1326.2011.01428.x.

9.

Solubilized nasal steroid (CDX-947) when combined in the same solution nasal spray with an antihistamine (CDX-313) provides improved, fast-acting symptom relief in patients with allergic rhinitis.

Salapatek AM, Lee J, Patel D, D'Angelo P, Liu J, Zimmerer RO Jr, Pipkin JD.

Allergy Asthma Proc. 2011 May-Jun;32(3):221-9. doi: 10.2500/aap.2011.32.3444. Epub 2011 Apr 8.

PMID:
21477425
10.

Percutaneous absorption in man: in vitro-in vivo correlation.

Lehman PA, Raney SG, Franz TJ.

Skin Pharmacol Physiol. 2011;24(4):224-30. doi: 10.1159/000324884. Epub 2011 Mar 31.

11.

Treatment of elderly patients with type 2 diabetes mellitus: a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors.

Schwartz SL.

Am J Geriatr Pharmacother. 2010 Oct;8(5):405-18. doi: 10.1016/j.amjopharm.2010.10.003. Review.

PMID:
21335294
12.

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.

Schwartz S, Etropolski M, Shapiro DY, Okamoto A, Lange R, Haeussler J, Rauschkolb C.

Curr Med Res Opin. 2011 Jan;27(1):151-62. doi: 10.1185/03007995.2010.537589.

PMID:
21162697
13.

Mometasone furoate nasal spray provides early, continuing relief of nasal congestion and improves nasal patency in allergic patients.

Salapatek AM, Patel P, Gopalan G, Varghese ST.

Am J Rhinol Allergy. 2010 Nov-Dec;24(6):433-8. doi: 10.2500/ajra.2010.24.3548. Epub 2010 Nov 10.

PMID:
21067660
14.

Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study.

Kipnes MS, Roth EM, Rhyne JM, Setze CM, Lele A, Kelly MT, Sleep DJ, Stolzenbach JC.

Clin Drug Investig. 2010;30(1):51-61. doi: 10.2165/11319800-000000000-00000.

PMID:
19995098
15.

Clinical performance of the TRUE2go blood glucose system--a novel integrated system for meter and strips.

Kipnes MS, Joseph H, Morris H, Manko J, Bell DE.

Diabetes Technol Ther. 2009 Oct;11(10):649-55. doi: 10.1089/dia.2009.0020.

PMID:
19821757
16.

Use of excised human skin to assess the bioequivalence of topical products.

Franz TJ, Lehman PA, Raney SG.

Skin Pharmacol Physiol. 2009;22(5):276-86. doi: 10.1159/000235828. Epub 2009 Aug 26.

17.

Dapagliflozin: an emerging treatment option in type 2 diabetes.

Kipnes M.

Expert Opin Investig Drugs. 2009 Mar;18(3):327-34. doi: 10.1517/13543780902766794 . Review.

PMID:
19243283
18.

Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis.

Couroux P, Kunjibettu S, Hall N, Wingertzahn MA.

Ann Allergy Asthma Immunol. 2009 Jan;102(1):62-8. doi: 10.1016/S1081-1206(10)60110-X.

PMID:
19205288
19.

Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.

Patel P, Patel D.

Ann Allergy Asthma Immunol. 2008 Sep;101(3):287-94. doi: 10.1016/S1081-1206(10)60494-2.

PMID:
18814452

Supplemental Content

Loading ...
Support Center